Antibody discovery companies develop platforms and services for identifying antibodies used in therapeutics, diagnostics and life science research. Their technologies support candidate discovery, screening, optimisation and early development.
This category includes companies working on:
Browse 63 UK antibody discovery companies below.
Cancer Research UK's translational and commercialisation arm
Cancer Research Horizons is the translational subsidiary of Cancer Research UK, operating at the interface between academic research and industry. The organisation combines…
Light-controlled droplet microfluidics for single-cell functional analysis
Lightcast Discovery is a life science tools company developing a droplet-based system for single-cell functional analysis. Using light to precisely control picolitre-scale…
Shark-derived single-domain antibody biologics for cancer and inflammation
Elasmogen is a biotechnology company developing next-generation therapeutic biologics based on its proprietary soloMER platform, single-domain antibody-like proteins derived from…
Biparatopic PD-1/VEGFR2 antibody for solid tumour oncology
Ottimo Pharma is a clinical-stage biotechnology company developing biparatopic antibody therapeutics for solid tumour cancers. Its lead programme, Jankistomig, is a first-in-class…
Therapeutic antibodies targeting the angiotensin AT1R pathway in cancer
aTen Therapeutics is a Scottish pre-clinical biotechnology company developing therapeutic monoclonal antibodies against the angiotensin-II type I receptor (AT1R), which is…
Ultra-high-throughput biologics discovery platform powered by generative AI
Sortera Bio is a biotechnology company developing an AI-powered platform for the discovery and engineering of biological therapeutics. The Deep Screening platform generates…
Medical research charity translating science into treatments and diagnostics
LifeArc is a self-funded UK medical research charity focused on translating early-stage science into treatments and diagnostics for patients with rare diseases and global health…
Generative AI platform for T cell receptor and antibody therapeutics
Etcembly is a biotech company using generative AI to discover and engineer T cell receptor and antibody therapeutics. The company's platform applies large language models to TCR…
Novel ADC payloads targeting NMT enzymes in cancer
Myricx Bio is a clinical-stage biotechnology company developing a novel class of antibody-drug conjugate payloads based on inhibition of N-myristoyltransferase, an enzyme…
Synthetic VHH antibody libraries and discovery services
Isogenica is a contract discovery company specialising in VHH single-domain antibody discovery, offering what it describes as the world's largest synthetic VHH library alongside…
Single-cell cloning and clone characterisation instruments for biopharma
Advanced Instruments is an instrumentation company developing and manufacturing products for the upstream cell line development workflow in biopharmaceutical and cell and gene…
Small molecule theranostics to improve transplant outcomes
Kairos Biotech is an early-stage biotechnology company developing proprietary small molecules and nanoscale-engineered binders for application in transplant diagnostics and…